Clovis Oncology, Inc.
Pharmaceutical Preparations · 5500 FLATIRON PARKWAY, SUITE 100, BOULDER, CO 80301
공식 등기 데이터
0팔로워
2009설립
Clovis Oncology, Inc. 소개
Clovis Oncology is an American pharmaceutical company which mainly markets products for treatment in oncology. Clovis was founded in 2009 and is headquartered in Boulder, Colorado. The company is a publicly traded company on NASDAQ under the symbol CLVS and is in the NASDAQ Biotechnology Index with several products in its product pipeline. As of December 31, 2017, the company was not profitable and had incurred losses in each year since its inception in April 2009. In December 2022, Clovis Oncology filed for Chapter 11 bankruptcy.
Source: Wikipedia
산업Pharmaceutical Preparations
본사5500 FLATIRON PARKWAY, SUITE 100, BOULDER, CO 80301
설립2009
법적 형태C Corporation
상태운영 중
특허특허 41건
IMMUNOSTIMULATORY AGENTS IN COMBINATION WITH ANGIOGENESIS INHIBITORSEP4135752A4 · 2024
HIGH DOSAGE STRENGTH TABLETS OF RUCAPARIBCA2955495C · 2023
주요 수치
법적 정보
| 법인명 | Clovis Oncology, Inc. |
|---|---|
| 법적 형태 | C Corporation |
| SEC CIK | 1466301SEC EDGAR에서 보기 ↗ |
| EIN | 90-0475355 |
| 업종 코드(SIC) | 2834 |
| 등기 주소 | 5500 FLATIRON PARKWAY, SUITE 100, BOULDER, CO 80301 |
| 상태 | 운영 중 |
출처: SEC EDGAR · 2026년 10월 15일 업데이트
연락처 및 링크
위치
5500 FLATIRON PARKWAY, SUITE 100, BOULDER, CO 80301
귀하의 회사인가요?
이 페이지를 무료로 신청하여 로고, 제품, 사진, 채용 공고를 추가하고 리뷰에 답변하세요.
이 페이지 신청